NCT00002552: Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma |
|
|
| Completed | 2 | 40 | US | filgrastim, sargramostim, carmustine, cyclophosphamide, cytarabine, etoposide, leucovorin calcium, methotrexate, perfosfamide, therapeutic hydrocortisone, allogeneic bone marrow transplantation, autologous bone marrow transplantation, in vitro-treated bone marrow transplantation, peripheral blood stem cell transplantation, syngeneic bone marrow transplantation, radiation therapy | Barbara Ann Karmanos Cancer Institute, National Cancer Institute (NCI) | Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm | 09/01 | 10/03 | | |
